Highly penetrant variants of the APC and BRCA2 genes were also implicated in several rare variant association studies in pancreatic cancer patient families [29,30,31,32,33,34], indicating that they could be potential targets for new associations. This evidence concerns the gene BRCA2 and pancreatic neoplasm.